Although there is no indication that heterozygous carriers are at an increased risk of developing disease (Tefs et al. 2006), PLG dysregulation could lead to an increased susceptibility to inflammatory and autoimmune diseases. The gene discussed is PLG; the disease is autoimmune disease.